Prime Medicine, Inc. (PRME)

3.255 -0.14 (-3.98%) USD  |  NASDAQ  |  Aug 24, 16:00
3.26 0.00 (0.00%) After-Hours: 20:00
More

Prime Medicine EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for PRME.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Sana Biotechnology, Inc. Upgrade
Generate Biomedicines, Inc. --
Intellia Therapeutics, Inc. Upgrade